70% af patienterne, som behandles med Rebif, kan forvente at opleve det typiske influenzalignende interferon- symptom inden for de første seks måneder efter start af behandlingen.
Approximately 70% of patients treated with Rebif can expect to experience the typical interferon flu-like syndrome within the first six months after starting treatment.